EMD-66861

Single-particle
2.8 Å
EMD-66861
3D View Gallery
Deposition: 31/10/2025
Map released: 09/09/2026
Last modified: 09/09/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-66861

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9xgx summary report (pdf.gz) Map-9xgx FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with SR-23 Fab (local refinement of RBD and Fv)

EMD-66861

Single-particle
2.8 Å
EMD-66861
3D View Gallery
Deposition: 31/10/2025
Map released: 09/09/2026
Last modified: 09/09/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2 receptor binding domain in complex with SR-23 Fab
Fitted models: 9xgx

Deposition Authors: Kim UJ, Wang DM, Yoon GY, Cho HS
Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus-2.
Kim DS, Kim U, Woo HM, Lee H, Jo ES, Noh MJ, Lee SY, Park BK, Yang JS, Kim KC, Lee JY, Wang DM, Cho HS, Kim HJ
(2026) J Med Virol , 98 , e70969 - e70969
PUBMED: 42126192
DOI: doi:10.1002/jmv.70969
ISSN: 1096-9071